STME (Stimcell Energetics) Debt-to-Equity: -0.47 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STME Stimcell Energetics Inc STME
26 GF Score
Price $0.28
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics Debt-to-Equity?

Stimcell Energetics STME 26 Debt-to-Equity is -0.47 as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 704 Medical Devices & Instruments companies, Stimcell Energetics ranks worse than 142045.31% on this metric.

Stimcell Energetics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was $0.01 Mil. Stimcell Energetics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was $0.77 Mil. Stimcell Energetics's Total Stockholders Equity for the quarter that ended in Feb. 2026 was $-1.68 Mil. Stimcell Energetics's debt to equity for the quarter that ended in Feb. 2026 was -0.46.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Stimcell Energetics's Debt-to-Equity or its related term are showing as below:

STME' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.68   Med: -0.35   Max: -0.11
Current: -0.47

During the past 13 years, the highest Debt-to-Equity Ratio of Stimcell Energetics was -0.11. The lowest was -0.68. And the median was -0.35.

STME's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.23 vs STME: -0.47

Stimcell Energetics  (OTCPK:STME) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Stimcell Energetics Debt-to-Equity Related Terms

Stimcell Energetics Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics Debt-to-Equity Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.31 -0.42 -0.38 -0.37

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -0.37 -0.41 -0.45 -0.47

STME vs NVNO, TRIB, AIDX: Debt-to-Equity Comparison

For the Medical Devices subindustry, Stimcell Energetics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stimcell Energetics Debt-to-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's Debt-to-Equity falls into.


STME
26GF Score
Stimcell Energetics Inc STME
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Stimcell Energetics's Debt to Equity Ratio for the fiscal year that ended in May. 2025 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.459 + 0) / -1.246
=-0.37

Stimcell Energetics's Debt to Equity Ratio for the quarter that ended in Feb. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.011 + 0.769) / -1.678
=-0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of -0.47 mean?
Stimcell Energetics (STME) has a Debt-to-Equity of -0.47 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #999999 out of 704 companies in the Medical Devices & Instruments industry.
Is Stimcell Energetics' Debt-to-Equity too high?
Stimcell Energetics' current Debt-to-Equity is -0.47. Based on the distribution chart, Stimcell Energetics ranks #999999 out of 704 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stimcell Energetics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' Debt-to-Equity compare to NVNO and TRIB?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #999999 out of 704 companies for Debt-to-Equity. This places Stimcell Energetics in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Stimcell Energetics and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stimcell Energetics's current Debt-to-Equity is -0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current Debt-to-Equity of -0.47. The current Debt-to-Equity is -0.47. Stimcell Energetics' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Stimcell Energetics (STME), the current Debt-to-Equity is -0.47 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
26GF Score

Get the complete analysis for STME

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price